This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Duke University, Massachusetts Institute of Technology. Active years: 2020.
Company Filing History:
1 out of 2,074 
1 out of 8,573 
Years Active: 2020
Title: Benjamin David Auerbach: Innovator in Fragile X Syndrome Treatment
Introduction
Benjamin David Auerbach is a notable inventor based in Buffalo, NY (US). He has made significant contributions to the field of medical research, particularly in the treatment of fragile X syndrome and related disorders. His innovative methodologies have the potential to impact many lives.
Latest Patents
Auerbach holds a patent titled "Methods of treating fragile X syndrome and related disorders." This patent discloses novel methodologies for treating fragile X syndrome by inhibiting mGlu-relevant signaling pathways. The approach involves reducing β-arrestin2 protein levels or diminishing mGlu and β-arrestin2 protein interactions. He has 1 patent to his name.
Career Highlights
Throughout his career, Auerbach has worked with prestigious institutions such as the Massachusetts Institute of Technology and Duke University. His work in these environments has allowed him to develop and refine his innovative ideas.
Collaborations
Auerbach has collaborated with notable individuals in his field, including Mark Firman Bear and Laura Jane Stoppel. These collaborations have contributed to the advancement of research in fragile X syndrome.
Conclusion
Benjamin David Auerbach is a pioneering inventor whose work in treating fragile X syndrome showcases his dedication to medical innovation. His contributions are vital to the ongoing research and development in this important area of health.